Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Akari Therapeutics plc ADR | -3.980% | - | - | - | - | - | - |
| co.don AG | -3.980% | - | - | - | - | - | - |
| Immunovaccine Inc | -3.890% | - | - | - | - | - | - |
| Lantheus Holdings Inc | -3.840% | 14.486% | 28.441% | -5.925% | 24.609% | - | - |
| Poxel S.A. | -3.810% | -12.184% | -3.141% | -10.194% | 2.778% | -91.527% | -92.238% |
| Puma Biotechnology Inc. | -3.780% | -0.528% | -8.316% | 90.717% | 15.749% | -44.851% | - |
| OncoCyte Corp | -3.610% | - | - | - | - | - | - |
| Saniona AB | -3.570% | -1.964% | -4.978% | -75.134% | -60.845% | -94.192% | - |
| CVS Group plc | -3.540% | -2.679% | -0.909% | -54.202% | -44.388% | -56.677% | 48.704% |
| Nicox S.A. | -3.490% | 0.876% | -5.730% | -40.431% | -15.422% | -91.634% | -93.554% |
| Haemato AG Inh.-Wand.gen.s.1 2005/unbegr. | -3.325% | - | - | - | - | - | - |
| Aspira Womens Health Inc. | -3.310% | -3.947% | 16.800% | -33.787% | -27.901% | -95.823% | -82.415% |
| 4 SC AG | -3.280% | - | - | - | - | - | - |
| Eagle Pharmaceuticals Inc | -3.160% | -9.859% | -8.134% | -84.882% | -14.286% | -89.091% | -91.096% |
| Mesoblast Ltd ADR | -3.160% | - | - | - | - | - | - |
| Cicassia Pharmaceuticals | -3.140% | 2.667% | 6.944% | 52.475% | 10.000% | 105.882% | 128.487% |
| Otsuka Holdings Co. Ltd. | -3.030% | 2.674% | 0.000% | 24.675% | 15.663% | 23.871% | 22.060% |
| Savara Inc. | -3.030% | - | - | - | - | - | - |
| Intra-Cellular Therapies Inc. | -3.030% | -7.246% | 2.400% | 13.879% | -1.840% | 133.747% | 408.744% |
| Forte Biosciences Inc. | -3.010% | -2.273% | 3.200% | -32.105% | 0.000% | -97.836% | - |
| Pieris Pharmaceuticals Inc | -2.980% | - | - | - | - | - | - |
| Acorda Therapeutics Cdt | -2.970% | - | - | - | - | - | - |
| Kala Pharmaceuticals Inc. | -2.870% | 5.913% | -14.346% | -54.072% | -6.595% | -97.907% | - |
| Biotest AG VZ | -2.770% | -1.042% | -0.350% | -9.236% | -8.065% | -2.062% | 27.803% |
| Pluristem Therapeutics Inc. | -2.750% | - | - | - | - | - | - |